Rhett JM - Search Results

1

Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Khan I, Koide A, Zuberi M, Ketavarapu G, Denbaum E, Teng KW, Rhett JM, Spencer-Smith R, Hobbs GA, Camp ER, Koide S, O'Bryan JP. Khan I, et al. Among authors: rhett jm. Cell Rep. 2022 Feb 8;38(6):110322. doi: 10.1016/j.celrep.2022.110322. Cell Rep. 2022. PMID: 35139380 Free PMC article.

2

Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Khan I, Rhett JM, O'Bryan JP. Khan I, et al. Among authors: rhett jm. Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118570. doi: 10.1016/j.bbamcr.2019.118570. Epub 2019 Oct 31. Biochim Biophys Acta Mol Cell Res. 2020. PMID: 31678118 Free PMC article. Review.

3

Biology, pathology, and therapeutic targeting of RAS.

Rhett JM, Khan I, O'Bryan JP. Rhett JM, et al. Adv Cancer Res. 2020;148:69-146. doi: 10.1016/bs.acr.2020.05.002. Epub 2020 Jul 9. Adv Cancer Res. 2020. PMID: 32723567 Free PMC article. Review.

4

Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1.

Rhett JM, Jourdan J, Gourdie RG. Rhett JM, et al. Mol Biol Cell. 2011 May;22(9):1516-28. doi: 10.1091/mbc.E10-06-0548. Epub 2011 Mar 16. Mol Biol Cell. 2011. PMID: 21411628 Free PMC article.

5

Connexin 43, breast cancer tumor suppressor: Missed connections?

Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: rhett jm. Cancer Lett. 2016 Apr 28;374(1):117-126. doi: 10.1016/j.canlet.2016.02.008. Epub 2016 Feb 13. Cancer Lett. 2016. PMID: 26884256 Review.

6

Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.

Rhett JM, Fann SA, Yost MJ. Rhett JM, et al. Tissue Eng Part B Rev. 2014 Oct;20(5):392-402. doi: 10.1089/ten.TEB.2013.0554. Epub 2014 Jan 16. Tissue Eng Part B Rev. 2014. PMID: 24279914 Free PMC article. Review.

7

Mechanism of action of the anti-inflammatory connexin43 mimetic peptide JM2.

Rhett JM, Calder BW, Fann SA, Bainbridge H, Gourdie RG, Yost MJ. Rhett JM, et al. Am J Physiol Cell Physiol. 2017 Sep 1;313(3):C314-C326. doi: 10.1152/ajpcell.00229.2016. Epub 2017 Jul 12. Am J Physiol Cell Physiol. 2017. PMID: 28701358 Free PMC article.

8

The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response.

Rhett JM, Yeh ES. Rhett JM, et al. Int J Mol Sci. 2018 Mar 30;19(4):1043. doi: 10.3390/ijms19041043. Int J Mol Sci. 2018. PMID: 29601539 Free PMC article. Review.

9

The connexin43 carboxyl terminus and cardiac gap junction organization.

Palatinus JA, Rhett JM, Gourdie RG. Palatinus JA, et al. Among authors: rhett jm. Biochim Biophys Acta. 2012 Aug;1818(8):1831-43. doi: 10.1016/j.bbamem.2011.08.006. Epub 2011 Aug 9. Biochim Biophys Acta. 2012. PMID: 21856279 Free PMC article. Review.

10

The perinexus: a new feature of Cx43 gap junction organization.

Rhett JM, Gourdie RG. Rhett JM, et al. Heart Rhythm. 2012 Apr;9(4):619-23. doi: 10.1016/j.hrthm.2011.10.003. Epub 2011 Oct 4. Heart Rhythm. 2012. PMID: 21978964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters